BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34611230)

  • 21. Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis.
    Sadhwani N; Aggarwal A; Mishra A; Garg K
    Neurosurg Rev; 2022 Dec; 45(6):3619-3628. PubMed ID: 36350492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Skeletal Muscle Depletion on Head and Neck Squamous Cell Carcinoma.
    Nishikawa D; Hanai N; Suzuki H; Koide Y; Beppu S; Hasegawa Y
    ORL J Otorhinolaryngol Relat Spec; 2018; 80(1):1-9. PubMed ID: 29393251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy.
    Zeng C; Zhai T; Chen J; Guo L; Huang B; Guo H; Liu G; Zhuang T; Liu W; Luo T; Wu Y; Peng G; Li D; Chen C
    Radiat Oncol; 2021 Jan; 16(1):8. PubMed ID: 33436018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Fattouh M; Chang GY; Ow TJ; Shifteh K; Rosenblatt G; Patel VM; Smith RV; Prystowsky MB; Schlecht NF
    Head Neck; 2019 Mar; 41(3):707-714. PubMed ID: 30582237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of bone metastases from head and neck squamous cell carcinoma.
    Suzuki A; Kashiwagi N; Doi H; Ishii K; Doi K; Kitano M; Kozuka T; Hyodo T; Tsurusaki M; Yagyu Y; Nakanishi K
    Auris Nasus Larynx; 2020 Apr; 47(2):262-267. PubMed ID: 31445714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation.
    Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A
    Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A PET/CT-Based Strategy Is a Stronger Predictor of Survival Than a Standard Imaging Strategy in Patients with Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2018 Apr; 59(4):575-581. PubMed ID: 28864630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 29. FDG-PET/contrast-enhanced CT as a post-treatment tool in head and neck squamous cell carcinoma: comparison with FDG-PET/non-contrast-enhanced CT and contrast-enhanced CT.
    Suenaga Y; Kitajima K; Ishihara T; Sasaki R; Otsuki N; Nibu K; Minamikawa T; Kiyota N; Sugimura K
    Eur Radiol; 2016 Apr; 26(4):1018-30. PubMed ID: 26188656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma.
    Roberti E; Merlano M; Ravanelli M; Alberti A; Esposito A; Gili R; Spinazzé S; Baré C; Jocollé G; Benasso M; Bertolotti F; Vecchio S; Bacigalupo A; Licitra L; Denaro N; Damico M; Lorini L; Gurizzan C; Alfieri S; Bossi P
    Oral Oncol; 2023 Oct; 145():106540. PubMed ID: 37567147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT-measured skeletal muscle mass used to assess frailty in patients with head and neck cancer.
    Zwart AT; van der Hoorn A; van Ooijen PMA; Steenbakkers RJHM; de Bock GH; Halmos GB
    J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1060-1069. PubMed ID: 31134765
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incremental Prognostic Value of Apparent Diffusion Coefficient Histogram Analysis in Head and Neck Squamous Cell Carcinoma.
    Li X; Yuan Y; Ren J; Shi Y; Tao X
    Acad Radiol; 2018 Nov; 25(11):1433-1438. PubMed ID: 29599009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
    Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
    PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases.
    Furtner J; Berghoff AS; Schöpf V; Reumann R; Pascher B; Woitek R; Asenbaum U; Pelster S; Leitner J; Widhalm G; Gatterbauer B; Dieckmann K; Höller C; Prayer D; Preusser M
    J Neurooncol; 2018 Oct; 140(1):173-178. PubMed ID: 30008154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Sarcopenia With Oncologic Outcomes of Primary Surgery or Definitive Radiotherapy Among Patients With Localized Oropharyngeal Squamous Cell Carcinoma.
    Olson B; Edwards J; Stone L; Jiang A; Zhu X; Holland J; Li R; Andersen P; Krasnow S; Marks DL; Clayburgh D
    JAMA Otolaryngol Head Neck Surg; 2020 Aug; 146(8):714-722. PubMed ID: 32525518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Temporalis Muscle Thickness as an Indicator of Sarcopenia Is Associated With Long-term Motor Outcomes in Parkinson's Disease.
    Chung SJ; Kim YJ; Yoo HS; Jung JH; Baik K; Lee HS; Lee YH; Hong JM; Sohn YH; Lee PH
    J Gerontol A Biol Sci Med Sci; 2021 Nov; 76(12):2242-2248. PubMed ID: 33754634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy.
    Kuno H; Qureshi MM; Chapman MN; Li B; Andreu-Arasa VC; Onoue K; Truong MT; Sakai O
    AJNR Am J Neuroradiol; 2017 Dec; 38(12):2334-2340. PubMed ID: 29025727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.